Cargando…

Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole

Pulmonary mucormycosis is a rare opportunistic invasive fungal infection that disproportionately affects immunocompromised hosts and carries high morbidity and mortality. It is traditionally treated with combined pharmacologic and surgical modalities. Here we present a case of pulmonary mucormycosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Huggins, Jonathan, Al Jurdi, Ayman, Gupta, Renuka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290088/
https://www.ncbi.nlm.nih.gov/pubmed/30560048
http://dx.doi.org/10.1016/j.mmcr.2018.11.004
_version_ 1783380029078503424
author Huggins, Jonathan
Al Jurdi, Ayman
Gupta, Renuka
author_facet Huggins, Jonathan
Al Jurdi, Ayman
Gupta, Renuka
author_sort Huggins, Jonathan
collection PubMed
description Pulmonary mucormycosis is a rare opportunistic invasive fungal infection that disproportionately affects immunocompromised hosts and carries high morbidity and mortality. It is traditionally treated with combined pharmacologic and surgical modalities. Here we present a case of pulmonary mucormycosis in a patient whose disease burden precluded surgical management, and in whom acute kidney injury necessitated therapy with an alternative to the recommended pharmacologic antifungal therapy.
format Online
Article
Text
id pubmed-6290088
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-62900882018-12-17 Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole Huggins, Jonathan Al Jurdi, Ayman Gupta, Renuka Med Mycol Case Rep Case Report Pulmonary mucormycosis is a rare opportunistic invasive fungal infection that disproportionately affects immunocompromised hosts and carries high morbidity and mortality. It is traditionally treated with combined pharmacologic and surgical modalities. Here we present a case of pulmonary mucormycosis in a patient whose disease burden precluded surgical management, and in whom acute kidney injury necessitated therapy with an alternative to the recommended pharmacologic antifungal therapy. Elsevier 2018-12-01 /pmc/articles/PMC6290088/ /pubmed/30560048 http://dx.doi.org/10.1016/j.mmcr.2018.11.004 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Huggins, Jonathan
Al Jurdi, Ayman
Gupta, Renuka
Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
title Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
title_full Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
title_fullStr Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
title_full_unstemmed Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
title_short Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
title_sort breaking the mold: a case of pulmonary mucormycosis treated with isavuconazole
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290088/
https://www.ncbi.nlm.nih.gov/pubmed/30560048
http://dx.doi.org/10.1016/j.mmcr.2018.11.004
work_keys_str_mv AT hugginsjonathan breakingthemoldacaseofpulmonarymucormycosistreatedwithisavuconazole
AT aljurdiayman breakingthemoldacaseofpulmonarymucormycosistreatedwithisavuconazole
AT guptarenuka breakingthemoldacaseofpulmonarymucormycosistreatedwithisavuconazole